IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


(Investigative Ophthalmology and Visual Science. 2005;46:797-802.)
© 2005 by The Association for Research in Vision and Ophthalmology, Inc.
DOI:  10.1167/iovs.04-1016

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fujitsu, Y.
Right arrow Articles by Nishida, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fujitsu, Y.
Right arrow Articles by Nishida, T.

Protection of Human Conjunctival Fibroblasts from NO-Induced Apoptosis by Interleukin-4 or Interleukin-13

Youichiro Fujitsu,1 Ken Fukuda,2 Kazuhiro Kimura,1 Keisuke Seki,2 Naoki Kumagai,1 and Teruo Nishida1

1From the Departments of Biomolecular Recognition and Ophthalmology and 2Ocular Pathophysiology, Yamaguchi University School of Medicine, Ube City, Yamaguchi, Japan.


    Abstract
 Top
 Abstract
 Methods
 Results
 Discussion
 References
 
PURPOSE. To examine the possible roles of T helper type 2 (Th2) cell–derived cytokines in formation of the giant papillae characteristic in individuals with vernal keratoconjunctivitis, the effects of these cytokines on the proliferation and apoptosis of cultured human conjunctival fibroblasts were investigated.

METHODS. Apoptosis was induced by the NO donor sodium nitroprusside. Cell viability was determined by measurement of mitochondrial metabolic activity, and apoptotic cells were identified on the basis either of nuclear morphology after staining with 4',6-diamidino-2-phenylindole or of TUNEL staining. The activation of antiapoptotic signaling mediated by the protein kinase Akt was assessed by immunoblot analysis and by an in vitro kinase assay. Expression of interleukin (IL)-4 and IL-13 receptor subunits was examined by reverse transcription and polymerase chain reaction analysis and by flow cytometry.

RESULTS. IL-4 and IL-13, but not IL-5, IL-9, or IL-10, induced the proliferation of conjunctival fibroblasts as well as protecting these cells from NO-induced apoptosis. Both IL-4 and IL-13 induced the phosphorylation of Akt and increased the kinase activity of this enzyme in a manner that was sensitive to the phosphatidylinositol 3-kinase inhibitors LY294002 or wortmannin. These inhibitors also blocked the antiapoptotic effects of IL-4 and IL-13. Transcripts encoding IL-4 and IL-13 receptor components were detected in conjunctival fibroblasts, and the proteins were expressed at the cell surface.

CONCLUSIONS. Among the various Th2 cytokines tested, only IL-4 and IL-13 induced the proliferation of human conjunctival fibroblasts and protected these cells from apoptosis. These effects may contribute to the formation of giant papillae in individuals with vernal keratoconjunctivitis.


Vernal keratoconjunctivitis (VKC) is a severe and chronic ocular allergic disease that threatens vision as a result of the associated corneal disorders such as corneal epithelial erosion and shield ulcer.1 A specific clinical characteristic of VKC is the formation of conjunctival giant papillae at the upper tarsus. These giant papillae develop as the result of overgrowth of resident conjunctival fibroblasts,2 infiltration of inflammatory cells such as eosinophils, mast cells, and T helper type 2 (Th2) cells,3 as well as excessive deposition of extracellular matrix proteins such as fibronectin and collagen types I and III.2

Cell proliferation and programmed cell death (apoptosis) play important roles in the maintenance of tissue integrity. An imbalance between these two processes contributes to the pathogenesis of various diseases.4 Certain cytokines and growth factors promote cell proliferation, whereas others protect cells against apoptosis by triggering specific survival signals. The overgrowth of conjunctival fibroblasts that contributes to the development of giant papillae might thus result from an imbalance between cell proliferation and cell death induced by cytokines or growth factors released during allergic inflammation.

Interleukin (IL)-4 and IL-13 are Th2 cell–derived cytokines that induce immunoglobulin (Ig) isotype switching in B cells and maintain the production of IgE.5 These cytokines thus play important roles in the development of both ocular and systemic allergic reactions. The concentration of IL-4 is increased in the tear fluid of patients with VKC,6 and the number of T cells and mast cells that express IL-13 is also increased in such individuals.7 8 The functional receptors for these cytokines are expressed on various cell types including epithelial cells, endothelial cells, fibroblasts, and smooth muscle cells.9 Two types of IL-4 receptor (IL-4R) have been identified: The type I receptor is composed of the IL-4R{alpha} chain and the IL-2 receptor common {gamma} chain (IL-2R{gamma}c); the type II receptor comprises IL-4R{alpha} and the IL-13 receptor {alpha}1 chain (IL-13R{alpha}1) and also functions as a receptor for IL-13.

IL-4 and IL-13 act not only on inflammatory cells but also on tissue-resident fibroblasts. These cytokines thus appear to play important roles in the initiation and amplification of ocular allergic inflammation by inducing both the production of chemokines such as eotaxin (CCL11)10 11 12 and thymus- and activation-regulated chemokine (CCL17),13 14 as well as the expression of vascular cell adhesion molecule–115 in human corneal fibroblasts. Interleukin-4 may also contribute to the formation of conjunctival giant papillae by stimulating the proliferation of and the production of extracellular matrix by human conjunctival fibroblasts.16

To provide further insight into the pathogenesis of giant papillae, we have now investigated the possible survival-promoting (antiapoptotic) effects of Th2 cytokines in human conjunctival fibroblasts.


    Methods
 Top
 Abstract
 Methods
 Results
 Discussion
 References
 
Materials
Minimum essential medium (MEM) and fetal bovine serum (FBS) were obtained from GIBCO BRL (Grand Island, NY), sodium nitroprusside (SNP) and propidium iodide were from Sigma (St. Louis, MO), and 4',6-diamidino-2-phenylindole (DAPI) and Alexa Fluor 488–conjugated donkey antibodies to mouse or goat immunoglobulin G (IgG) were from Molecular Probes (Eugene, OR). Tissue culture dishes and cell culture plates (Falcon) were from Becton-Dickinson (Franklin Lakes, NJ). Recombinant human IL-4, IL-5, and IL-10 were from Genzyme Techne (Minneapolis, MN); recombinant human IL-9 and IL-13, a mouse monoclonal antibody to human IL-13R{alpha}1, goat polyclonal antibodies to human IL-13R{alpha}2, normal mouse IgG1, and normal goat IgG were from R&D Systems (Minneapolis, MN); a rat monoclonal antibody to human IL-2R{gamma}c was from Sumitomo Electric (Osaka, Japan); and normal rat IgG and fluorescein isothiocyanate–conjugated goat antibodies to rat IgG were from ICN Pharmaceuticals (Aurora, OH). An Akt kinase assay kit, rabbit polyclonal antibodies to Akt and to phospho-Akt (phosphoserine-473), as well as LY294002 were obtained from Cell Signaling (Beverly, MA); wortmannin was from Calbiochem (La Jolla, CA); and horseradish peroxidase–conjugated donkey antibodies to rabbit IgG and a terminal deoxynucleotidyl transferase–mediated dUTP-biotin nick-end labeling (TUNEL) assay kit were from Promega (Madison, WI). All reagents used for cell culture were endotoxin minimized.

Isolation and Culture of Human Conjunctival Fibroblasts
Three normal human conjunctivas were obtained after informed consent from individuals undergoing eyelid or strabismus surgery, and were processed separately. The human tissue was used in strict accordance with the basic principles of the Declaration of Helsinki. Conjunctival fibroblasts were isolated and cultured as described previously.16

Apoptosis Induction
The nitric oxide (NO) donor SNP was used as a proapoptotic agent because of its ability to induce apoptosis in fibroblasts.17 Cells were cultured for 24 hours in MEM supplemented with 0.5% FBS, for 48 hours in fresh medium further supplemented with cytokines, and for 6–24 hours in fresh medium supplemented with cytokines and 3 mM SNP. In some experiments, LY294002 or wortmannin was included in all incubations with cytokines.

Measurement of Cell Survival
Conjunctival fibroblasts were cultured and stimulated in 96-well plates (5 x 103 cells per well) as described above. After incubation for 24 hours with 3 mM SNP, the relative number of viable cells was estimated by measurement of mitochondrial 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H- tetrazolium (MTS)–metabolizing activity with the use of a Celltiter 96 Aqueous Non-Radioactive Cell Proliferation Assay (Promega), as described previously.16

Morphologic Evaluation and TUNEL Analysis of Apoptosis
The number of apoptotic cells was determined by morphologic evaluation18 as well as by the TUNEL assay17 as described previously. In brief, cells were cultured and stimulated in 8-well plates (5 x 103 cells per well) as described above, fixed with 4% paraformaldehyde, permeabilized with 0.2% Triton X-100, and subjected to the TUNEL assay. They were then counterstained with propidium iodide (1 µg /mL) and DAPI (0.3 µM) before observation with a fluorescence microscope (Axioskop 50; Zeiss, Oberkochen, Germany). The mean percentages of TUNEL-positive (apoptotic) cells as well as of apoptotic cells identified by characteristic chromatin condensation were determined by examination of three microscopic fields in each of three replicate cultures.

Immunoblot Analysis of Akt and Phospho-Akt
The phosphorylation of Akt was examined by immunoblot analysis as described previously.17 In brief, cells were cultured in 60-mm dishes (3 x 105 cells per dish) first for 48 hours in MEM supplemented with 0.5% FBS and then for an additional 2 hours in serum-free medium. They were then incubated for 5 minutes at 37°C with fresh serum-free medium containing various cytokines before lysis by scraping and sonication. The lysate was centrifuged, and the resulting supernatant was fractionated by SDS-polyacrylamide gel electrophoresis on a 10% gel. The separated proteins were transferred to a polyvinylidene difluoride membrane, which, after the blocking of nonspecific sites, was incubated with antibodies to phospho-Akt. Immune complexes were detected with horseradish peroxidase–conjugated secondary antibodies and enhanced chemiluminescence. The membrane was then reprobed with antibodies to Akt.

Assay of the Kinase Activity of Akt
The kinase activity of Akt was assayed with a kit. In brief, cells were cultured in 100-mm dishes and were exposed to cytokines for 15 minutes at 37°C in serum-free medium. They were then washed once with ice-cold phosphate-buffered saline and lysed with lysis buffer. Total cellular proteins were subjected to immunoprecipitation overnight at 4°C with agarose-conjugated monoclonal antibodies to Akt. The resulting precipitates were washed three times with lysis buffer and twice with kinase buffer and were then assayed for kinase activity for 30 minutes at 30°C with continuous agitation in kinase buffer containing 200 µM ATP and 1 µg of a glycogen synthase kinase–3 (GSK-3) fusion protein as substrate. The reaction was terminated by the addition of SDS sample buffer, and the reaction mixtures were then subjected to immunoblot analysis with polyclonal antibodies to phosphorylated GSK-3{alpha} or -3ß. Equal loading of samples was confirmed by reprobing of the membrane with monoclonal antibodies to Akt.

RT-PCR Analysis of IL-4 and IL-13 Receptor Components
The abundance of mRNAs for IL-4R and IL-13R components was determined by reverse transcription (RT) and polymerase chain reaction (PCR) analysis as described previously.12 16 Transcripts of the constitutively expressed gene for glyceraldehyde-3-phosphate dehydrogenase (GAPDH) served as an internal control. The sequences of the PCR primers for IL-4R{alpha}, IL-13R{alpha}1, IL-13R{alpha}2, IL-2R{gamma}c, and GAPDH were as described previously.12 19

Flow Cytometric Analysis of Cell Surface Expression of IL-4 and IL-13 Receptor Components
Cell surface expression of cytokine receptors was analyzed by flow cytometry as described previously.12 16 In brief, cells were incubated for 30 minutes at 4°C with antibodies to human IL-2R{gamma}c, IL-13R{alpha}1, or IL-13R{alpha}2. The cells were then washed, incubated for 30 minutes at 4°C with FITC-conjugated goat antibodies to rat IgG or Alexa Fluor 488–conjugated donkey antibodies to mouse or goat IgG, respectively, washed again, and fixed with 1% paraformaldehyde in phosphate-buffered saline. As a negative control, cells were incubated under similar conditions with rat, mouse, or goat IgG in place of the primary antibodies. Cells were then analyzed by flow cytometry with an EPICS-XL instrument; at least 10,000 cells were analyzed for each sample.

Statistical Analysis
Data were analyzed by Dunnett’s test or Scheffé’s multiple comparison test. A P value of <0.05 was considered statistically significant.


    Results
 Top
 Abstract
 Methods
 Results
 Discussion
 References
 
Antiapoptotic Effects of IL-4 and IL-13 in Human Conjunctival Fibroblasts
We first investigated the effects of Th2 cytokines on the proliferation of human conjunctival fibroblasts and on the induction of apoptosis in these cells by NO. Measurement of mitochondrial MTS-metabolizing activity revealed that IL-4 and IL-13, each at a concentration of 10 ng/mL, stimulated the proliferation of conjunctival fibroblasts, consistent with our previous observations with IL-4,16 whereas IL-5, IL-9, and IL-10 had no such effect (Fig. 1) . Exposure to the NO donor SNP (3 mM) for 24 hours resulted in the death of most cells, as revealed by the MTS survival assay (Fig. 1) . However, this assay also revealed that pretreatment of the cells with IL-4 or IL-13, but not with IL-5, IL-9, or IL-10, protected them from NO-induced cell death (Fig. 1) . Evaluation of nuclear morphology by DAPI staining showed that NO induced chromatin condensation characteristic of apoptosis in most cells and that this effect was blocked by IL-4 or IL-13 but was not inhibited by IL-5, IL-9, or IL-10 (Fig. 2) ; none of the cytokines tested alone affected nuclear morphology. To confirm that the cell death induced by SNP was indeed apoptosis, we performed the TUNEL assay. Exposure to SNP rendered most cells TUNEL positive, or apoptotic, and pretreatment of the cells with IL-4 or IL-13 protected them from SNP-induced apoptosis (Fig. 2) . These results thus demonstrated that IL-4 and IL-13 each protected human conjunctival fibroblasts from SNP-induced apoptosis.



View larger version (24K):
[in this window]
[in a new window]
 
FIGURE 1. Effects of Th2 cytokines on the proliferation and SNP-induced death of human conjunctival fibroblasts. Cells were pretreated with or without the indicated cytokines (10 ng/mL) for 48 hours and then incubated in the absence (open bars) or presence (hatched bars) of 3 mM SNP for an additional 24 hours in the continued absence or presence of cytokines. The relative number of viable cells was estimated by the MTS survival assay. Data are means ± SEM of values from five independent experiments. *P < 0.05, {dagger}P < 0.01 (Dunnett’s test) versus the corresponding values for no cytokine addition (minus and plus SNP, respectively).

 


View larger version (29K):
[in this window]
[in a new window]
 
FIGURE 2. Effects of Th2 cytokines on SNP-induced apoptosis in conjunctival fibroblasts. (AL) Cells were pretreated or not with the indicated cytokines (10 ng/mL) for 48 hours and then incubated in the additional absence (AC, GI) or presence (DF, JL) of 3 mM SNP for 24 hours. They were then subjected to the TUNEL assay and stained with DAPI (insets) before examination with a fluorescence microscope; for the TUNEL assay, cells were counterstained with propidium iodide. Scale bar, 100 µm. (M) The percentage of TUNEL-positive cells under the various conditions was determined. Data are means ± SEM of values from three independent experiments. *P < 0.01 versus the corresponding value (plus SNP) for no cytokine addition (Scheffé’s test).

 
Phosphorylation and Activation of Akt Induced by IL-4 or IL-13 in Conjunctival Fibroblasts
We next examined whether IL-4 or IL-13 induced the activation (phosphorylation) of Akt, which inhibits apoptosis and promotes cell survival.20 Conjunctival fibroblasts were incubated for 5 minutes with cytokines (100 ng/mL), lysed, and subjected to immunoblot analysis with antibodies to phospho-Akt and to Akt. The abundance of Akt was not affected by exposure of conjunctival fibroblasts to any of the cytokines examined. However, IL-4 and IL-13, but not IL-5, IL-9, or IL-10, induced a marked increase in the amount of phosphorylated Akt (Fig. 3A) . To determine whether the IL-4–or IL-13–induced activation of Akt in conjunctival fibroblasts was mediated by phosphatidylinositol (PI) 3-kinase, we examined the effects of the PI 3-kinase inhibitors LY294002 and wortmannin. Preincubation of cells with LY294002 (50 µM) or wortmannin (200 nM) almost completely inhibited the phosphorylation of Akt induced by IL-4 or IL-13 (Fig. 3B) . We confirmed the effects of IL-4 and IL-13 on Akt activation by measuring the kinase activity of the enzyme directly with an in vitro immune-complex kinase assay. Both IL-4 and IL-13 induced a marked increase in the kinase activity of Akt as determined with a GSK-3 fusion protein as substrate (Fig. 4A) . Preincubation of conjunctival fibroblasts with the PI 3-kinase inhibitors LY294002 (50 µM) or wortmannin (200 nM) blocked the increase in Akt activity induced by IL-4 or IL-13 (Fig. 4B) , suggesting that the activation of Akt by these cytokines is indeed mediated by PI 3-kinase.



View larger version (20K):
[in this window]
[in a new window]
 
FIGURE 3. Effects of Th2 cytokines on the phosphorylation of Akt in conjunctival fibroblasts. Cells were exposed for 5 minutes to the indicated cytokines (100 ng/mL) either without (A) or with (B) pretreatment for 60 minutes with the PI 3-kinase inhibitors LY294002 (LY, 50 µM) or wortmannin (WMN, 200 nM). They were then lysed and subjected to immunoblot analysis with antibodies to phospho-Akt (pAkt). The membrane was reprobed with antibodies to Akt. Data are representative of three independent experiments.

 


View larger version (16K):
[in this window]
[in a new window]
 
FIGURE 4. Effects of Th2 cytokines on the kinase activity of Akt in conjunctival fibroblasts. Cells were incubated for 15 minutes with the indicated cytokines (100 ng/mL) either without (A) or with (B) pretreatment for 60 minutes with the PI 3-kinase inhibitors LY294002 (LY, 50 µM) or wortmannin (WMN, 200 nM). Cell extracts were then subjected to immunoprecipitation with antibodies to Akt, and the resulting precipitates were subjected to an in vitro kinase assay with a GSK-3 fusion protein as substrate. The reaction mixtures were analyzed by immunoblotting with antibodies to phosphorylated GSK-3{alpha} or -3ß, and the membrane was reprobed with antibodies to Akt. Data are representative of three independent experiments.

 
Role of PI 3-Kinase in the Antiapoptotic Effects of IL-4 and IL-13 in Conjunctival Fibroblasts
We then examined the effect of the PI 3-kinase inhibitors on the antiapoptotic action of IL-4 or IL-13 in conjunctival fibroblasts. Pretreatment of the cells with IL-4 or IL-13 in the presence of LY294002 or wortmannin resulted in marked inhibition of the protective effect of these cytokines against SNP-induced apoptosis (Fig. 5) .



View larger version (14K):
[in this window]
[in a new window]
 
FIGURE 5. Effects of PI 3-kinase inhibitors on the antiapoptotic action of IL-4 or IL-13 in conjunctival fibroblasts. Cells were pretreated with or without IL-4 or IL-13 (10 ng/mL) and in the absence or presence of LY294002 (LY, 50 µM) or wortmannin (WMN, 200 nM) for 48 hours. They were then incubated for 24 hours in the additional absence or presence of 3 mM SNP before staining with DAPI and subjection to the TUNEL assay. The percentage of apoptotic (TUNEL-positive) cells was determined. Data are means ± SEM of values from three independent experiments. *P < 0.01 versus cells not exposed to any agent (Dunnett’s test).

 
Expression of IL-4 and IL-13 Receptors in Conjunctival Fibroblasts
Finally, whether human conjunctival fibroblasts express receptors for IL-4 and IL-13 was investigated. With the use of RT-PCR analysis and flow cytometry, we previously showed that these cells contain transcripts for the IL-4R{alpha} chain and express IL-4R{alpha} at the cell surface, respectively.16 In the present study, RT-PCR analysis of total RNA isolated from cultured human conjunctival fibroblasts also revealed the presence of transcripts encoding IL-2R{gamma}c, IL-13R{alpha}1, and IL-13R{alpha}2 (Fig. 6A) . Flow cytometric analysis also revealed the presence at the cell surface of IL-2R{gamma}c, IL-13R{alpha}1, and IL-13R{alpha}2 (Fig. 6B) .



View larger version (41K):
[in this window]
[in a new window]
 
FIGURE 6. Expression of IL-4 and IL-13 receptor components in conjunctival fibroblasts. (A) RT-PCR analysis. Total RNA isolated from conjunctival fibroblasts (CF) and from human monocytes as a positive control (P) was subjected to RT-PCR analysis with primers specific for IL-4R{alpha}, IL-13R{alpha}1, IL-13R{alpha}2, IL-2R{gamma}c, and GAPDH (internal control) cDNAs. No PCR products were detected in the absence (–) of reverse transcription (RT). The leftmost lanes contain DNA size markers. Data are representative of three experiments. (B) Flow cytometric analysis. Conjunctival fibroblasts were stained either with antibodies to human IL-2R{gamma}c, IL-13R{alpha}1, or IL-13R{alpha}2 (shaded histograms) or with isotype-matched control Ig (open histograms). Data are representative of two experiments.

 

    Discussion
 Top
 Abstract
 Methods
 Results
 Discussion
 References
 
We have shown that the Th2 cytokines IL-4 and IL-13 each significantly inhibit SNP-induced apoptosis in human conjunctival fibroblasts and that this effect appears to be mediated by the activation of PI 3-kinase and Akt. As we previously demonstrated for IL-4,16 these two cytokines also stimulated the proliferation of conjunctival fibroblasts. These observations thus suggest that the mitogenic and antiapoptotic effects of IL-4 and IL-13 in conjunctival fibroblasts might contribute to the formation of giant papillae in individuals with VKC.

The interaction of IL-4 and IL-13 with their receptors in immune cells results in activation of signaling pathways mediated by STAT6 and PI 3-kinase.21 We have now shown that two inhibitors of PI 3-kinase activity, wortmannin and the more specific compound LY294002, blocked the ability of IL-4 or IL-13 to protect conjunctival fibroblasts from SNP-induced apoptosis. Neither LY294002 nor wortmannin affected the phosphorylation or nuclear translocation of STAT6 induced by IL-4 or IL-13 in these cells (unpublished data). These results are consistent with previous observations with colonic epithelial cells and FDCP2 myeloid cells.22 23 The activation of STAT6 and that of PI 3-kinase in conjunctival fibroblasts thus appear to be distinct events, and the activation of PI 3-kinase seems to mediate the antiapoptotic effects of IL-4 and IL-13 in these cells.

The serine-threonine protein kinase Akt is a key downstream target of PI 3-kinase in the promotion of hematopoietic cell survival.24 Hematopoietic cells are dependent on the presence of specific cytokines for their continued proliferation and survival.24 In the absence of cytokines, the cells thus cease to proliferate and undergo apoptosis. We have now shown that tissue-resident fibroblasts were protected from NO-induced apoptosis by IL-4 or IL-13 as a result of the activation of the PI 3-kinase–Akt signaling pathway. Other Th2 cytokines, including IL-5, IL-9, and IL-10, did not activate Akt in human conjunctival fibroblasts, nor did they protect these cells from NO-induced apoptosis. The abundance of several growth factors has been shown to be increased in giant papillae.25 Given that Akt is activated by growth factors such as platelet-derived growth factor and insulin-like growth factor–1,17 these growth factors also might exert both mitogenic and antiapoptotic effects in giant papillae.

Oxidative stress caused by the production of superoxide, the hydroxyl radical, or NO is characteristic of many allergic disorders.26 NO is synthesized from L-arginine by a family of NO synthase enzymes and its production is increased in individuals with allergic asthma, allergic rhinitis, or atopic dermatitis.27 In addition, the amounts of NO and NO synthase are increased in an animal model of allergic conjunctivitis.28 NO induces apoptosis in many inflammatory cell types, including eosinophils and Th2 cells,27 29 both of which are major effector cells in allergic inflammation. We have now shown that the NO donor SNP induces apoptosis in human conjunctival fibroblasts. Although the contribution of NO to the pathogenesis of giant papillae remains to be determined, NO, together with IL-4 and IL-13, might be a determinant of the balance between the proliferation and apoptosis of human conjunctival fibroblasts in individuals with VKC.

The IL-4 and IL-13 receptors share a common chain, IL-4R{alpha}. Conjunctival fibroblasts express IL-2R{gamma}c, IL-13R{alpha}1, and IL-13R{alpha}2 chains at the mRNA and protein levels in addition to IL-4R{alpha}. These cells thus appear to express both type I (IL-4R{alpha} and IL-2R{gamma}c) and type II (IL-4R{alpha} and IL-13R{alpha}1) receptors for IL-4, the latter of which also functions as a receptor for IL-13.

In conclusion, IL-4 and IL-13 each promote the proliferation of human conjunctival fibroblasts as well as protect these cells from apoptosis. This latter effect appears to be mediated by activation of the PI 3-kinase–Akt signaling pathway. These actions of IL-4 and IL-13 might thus contribute to the overgrowth of conjunctival fibroblasts that is characteristic of the development of giant papillae in individuals with VKC.


    Footnotes
 
Submitted for publication August 24, 2004; revised November 9, 2004; accepted November 17, 2004.

Disclosure: Y. Fujitsu, None; K. Fukuda, None; K. Kimura, None; K. Seki, None; N. Kumagai, None; T. Nishida, None

The publication costs of this article were defrayed in part by page charge payment. This article must therefore be marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.

Corresponding author: Ken Fukuda, Department of Ocular Pathophysiology, Yamaguchi University School of Medicine, 1-1-1 Minami-Kogushi, Ube City, Yamaguchi 755-8505, Japan; k.fukuda{at}yamaguchi-u.ac.jp.


    References
 Top
 Abstract
 Methods
 Results
 Discussion
 References
 

  1. Bonini S, Bonini S, Lambiase A, et al. Vernal keratoconjunctivitis revisited: a case series of 195 patients with long-term followup. Ophthalmology. 2000;107:1157–1163.[CrossRef][ISI][Medline][Order article via Infotrieve]
  2. Leonardi A, Abatangelo G, Cortivo R, Secchi AG. Collagen types I and III in giant papillae of vernal keratoconjunctivitis. Br J Ophthalmol. 1995;79:482–485.[Abstract/Free Full Text]
  3. Maggi E, Biswas P, Del Prete G, et al. Accumulation of Th-2-like helper T cells in the conjunctiva of patients with vernal conjunctivitis. J Immunol. 1991;146:1169–1174.[Abstract]
  4. Evan GI, Vousden KH. Proliferation, cell cycle and apoptosis in cancer. Nature. 2001;411:342–348.[CrossRef][Medline][Order article via Infotrieve]
  5. Punnonen J, Aversa G, Cocks BG., et al. Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc Natl Acad Sci USA. 1993;90:3730–3734.[Abstract/Free Full Text]
  6. Fujishima H, Takeuchi T, Shinozaki N, Saito I, Tsubota K. Measurement of IL-4 in tears of patients with seasonal allergic conjunctivitis and vernal keratoconjunctivitis. Clin Exp Immunol. 1995;102:395–398.[ISI][Medline][Order article via Infotrieve]
  7. Anderson DF, Zhang S, Bradding P, et al. The relative contribution of mast cell subsets to conjunctival TH2-like cytokines. Invest Ophthalmol Vis Sci. 2001;42:995–1001.
  8. Calder VL, Jolly G, Hingorani M, et al. Cytokine production and mRNA expression by conjunctival T-cell lines in chronic allergic eye disease. Clin Exp Allergy. 1999;29:1214–1222.[CrossRef][ISI][Medline][Order article via Infotrieve]
  9. Khurana Hershey GK. IL-13 receptors and signaling pathways: an evolving web. J Allergy Clin Immunol. 2003;111:677–690.[ISI][Medline][Order article via Infotrieve]
  10. Kumagai N, Fukuda K, Ishimura Y, Nishida T. Synergistic induction of eotaxin expression in human keratocytes by TNF-{alpha} and IL-4 or IL-13. Invest Ophthalmol Vis Sci. 2000;41:1448–1453.[Abstract/Free Full Text]
  11. Fukuda K, Yamada N, Fujitsu Y, Kumagai N, Nishida T. Inhibition of eotaxin expression in human corneal fibroblasts by interferon-{gamma}. Int Arch Allergy Immunol. 2002;129:138–144.[CrossRef][ISI][Medline][Order article via Infotrieve]
  12. Fukuda K, Fujitsu Y, Kumagai N, Nishida T. Characterization of the interleukin-4 receptor complex in human corneal fibroblasts. Invest Ophthalmol Vis Sci. 2002;43:183–188.[Abstract/Free Full Text]
  13. Kumagai N, Fukuda K, Nishida T. Synergistic effect of TNF-{alpha} and IL-4 on the expression of thymus- and activation-regulated chemokine in human corneal fibroblasts. Biochem Biophys Res Commun. 2000;279:1–5.[CrossRef][ISI][Medline][Order article via Infotrieve]
  14. Fukuda K, Fujitsu Y, Seki K, Kumagai N, Nishida T. Differential expression of thymus- and activation-regulated chemokine (CCL17) and macrophage-derived chemokine (CCL22) by human fibroblasts from cornea, skin, and lung. J Allergy Clin Immunol. 2003;111:520–526.[ISI][Medline][Order article via Infotrieve]
  15. Kumagai N, Fukuda K, Fujitsu Y, Nishida T. Synergistic effect of TNF-{alpha} and either IL-4 or IL-13 on VCAM-1 expression by cultured human corneal fibroblasts. Cornea. 2003;22:557–561.[CrossRef][ISI][Medline][Order article via Infotrieve]
  16. Fujitsu Y, Fukuda K, Kumagai N, Nishida T. IL-4-induced cell proliferation and production of extracellular matrix proteins in human conjunctival fibroblasts. Exp Eye Res. 2003;76:107–114.[CrossRef][ISI][Medline][Order article via Infotrieve]
  17. Yanai R, Yamada N, Kugimiya N, Inui M, Nishida T. Mitogenic and antiapoptotic effects of various growth factors on human corneal fibroblasts. Invest Ophthalmol Vis Sci. 2002;43:2122–2126.[Abstract/Free Full Text]
  18. Relic B, Guicheux J, Mezin F, et al. IL-4 and IL-13, but not IL-10, protect human synoviocytes from apoptosis. J Immunol. 2001;166:2775–2782.[Abstract/Free Full Text]
  19. Palmer-Crocker RL, Hughes CCW, Pober JS. IL-4 and IL-13 activate the JAK2 tyrosine kinase and Stat6 in cultured human vascular endothelial cells through a common pathway that does not involve the {gamma}c chain. J Clin Invest. 1996;98:604–609.[ISI][Medline][Order article via Infotrieve]
  20. Kennedy SG, Wagner AJ, Conzen SD, et al. The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. Genes Dev. 1997;11:701–713.[Abstract/Free Full Text]
  21. Kelly-Welch AE, Hanson EM, Boothby MR, Keegan AD. Interleukin-4 and interleukin-13 signaling connections maps. Science. 2003;300:1527–1528.[Abstract/Free Full Text]
  22. Ceponis PJM, Botelho F, Richards CD, McKay DM. Interleukins 4 and 13 increase intestinal epithelial permeability by a phosphatidylinositol 3-kinase pathway. Lack of evidence for STAT 6 involvement. J Biol Chem. 2000;275:29132–29137.[Abstract/Free Full Text]
  23. Ahmad F, Gao G, Wang LM, et al. IL-3 and IL-4 activate cyclic nucleotide phosphodiesterases 3 (PDE3) and 4 (PDE4) by different mechanisms in FDCP2 myeloid cells. J Immunol. 1999;162:4864–4875.[Abstract/Free Full Text]
  24. Larrivée B, Lane DR, Pollet I, et al. Vascular endothelial growth factor receptor-2 induces survival of hematopoietic progenitor cells. J Biol Chem. 2003;278:22006–22013.[Abstract/Free Full Text]
  25. Leonardi A, Brun P, Tavolato M, et al. Growth factors and collagen distribution in vernal keratoconjunctivitis. Invest Ophthalmol Vis Sci. 2000;41:4175–4181.[Abstract/Free Full Text]
  26. Bowler RP, Crapo JD. Oxidative stress in allergic respiratory diseases. J Allergy Clin Immunol. 2002;110:349–356.[CrossRef][ISI][Medline][Order article via Infotrieve]
  27. Zhang X, Moilanen E, Lahti A, et al. Regulation of eosinophil apoptosis by nitric oxide: role of c-Jun-N-terminal kinase and signal transducer and activator of transcription 5. J Allergy Clin Immunol. 2003;112:93–101.[CrossRef][ISI][Medline][Order article via Infotrieve]
  28. Ko SM, Kim MK, Kim JC. The role of nitric oxide in experimental allergic conjunctivitis. Cornea. 2000;19:84–91.[CrossRef][ISI][Medline][Order article via Infotrieve]
  29. Roozendaal R, Vellenga E, de Jong MA, et al. Resistance of activated human Th2 cells to NO-induced apoptosis is mediated by {gamma}-glutamyltranspeptidase. Int Immunol. 2001;13:519–528.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
IOVSHome page
K. Fukuda, Y. Fujitsu, N. Kumagai, and T. Nishida
Inhibition of matrix metalloproteinase-3 synthesis in human conjunctival fibroblasts by interleukin-4 or interleukin-13.
Invest. Ophthalmol. Vis. Sci., July 1, 2006; 47(7): 2857 - 2864.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fujitsu, Y.
Right arrow Articles by Nishida, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fujitsu, Y.
Right arrow Articles by Nishida, T.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS